Original language | English |
---|---|
Pages (from-to) | 242-247 |
Number of pages | 6 |
Journal | Human Vaccines |
Volume | 5 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2009 |
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
Kalifa Bojang, Paul Milligan, Margaret Pinder, Tom Doherty, Amanda Leach, Opokua Ofori-Anyinam, Marc Lievens, Kent Kester, Kurt Schaecher, Ripley Ballou, Joe Cohen
Research output: Contribution to journal › Article › peer-review